BC Cancer, Harvard Medical School and Memorial Sloan Kettering Cancer Center (MSK) have pinpointed what could be the early ...

“Our new project at ARU aims to enhance our knowledge of the tumour microenvironment, uncover new molecules crucial for ...

Pancreatic cancer is one of the hardest cancers to detect early and treat effectively. By the time it’s discovered, it’s ...

Dr. Reid Bissonnette, Executive Consultant for Translational Research and Development at Xenetic, discusses positive ...

We recently compiled a list of the 10 Most Promising Cancer Stocks According to Hedge Funds. In this article, we are going to ...

We recently compiled a list of the 10 Most Promising Cancer Stocks According to Hedge Funds. In this article, we are going to ...

indicating cancer may progress earlier than previously thought. The I-SPY clinical trial platform was designed to accelerate clinical development of neoadjuvant treatments for early-stage breast ...

RGCB and CCRC signed an MoU for cancer research, therapy, and diagnostics, with RGCB providing expertise and lab facilities.

Researchers at Anglia Ruskin University (ARU) have secured funding from the US-based Colorectal Cancer Alliance to examine how fat tissue affects the development and progression of colorectal cancer.

To determine the type and severity of a cancer, pathologists typically analyze thin slices of a tumor biopsy under a microscope. But to figure out what genomic changes are driving the tumor's ...